Production (Stage)
Farmacias Benavides, S.A.B. de C.V.
FBNVF
OTC PK
| 12/31/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | ||
|---|---|---|---|---|---|
| Net Income | -- | 13.48M | 14.73M | 15.84M | |
| Total Depreciation and Amortization | -- | 59.20M | 56.58M | 55.63M | |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | |
| Total Other Non-Cash Items | -- | -9.44M | -16.07M | -13.20M | |
| Change in Net Operating Assets | -- | 1.23M | -1.32M | -6.52M | |
| Cash from Operations | -- | 64.47M | 53.92M | 51.75M | |
| Capital Expenditure | -- | -11.33M | -17.51M | -13.88M | |
| Sale of Property, Plant, and Equipment | -- | 728.70K | 1.06M | 890.20K | |
| Cash Acquisitions | -- | -- | -- | -- | |
| Divestitures | -- | -- | -- | -- | |
| Other Investing Activities | -- | -678.50K | -135.40K | -351.80K | |
| Cash from Investing | -- | -11.28M | -16.58M | -13.34M | |
| Total Debt Issued | -- | -- | -- | -- | |
| Total Debt Repaid | -- | -478.46M | -300.83M | -363.44M | |
| Issuance of Common Stock | -- | -- | -- | -- | |
| Repurchase of Common Stock | -- | -- | -- | -- | |
| Issuance of Preferred Stock | -- | -- | -- | -- | |
| Repurchase of Preferred Stock | -- | -- | -- | -- | |
| Total Dividends Paid | -- | -- | -- | -- | |
| Other Financing Activities | -- | -328.35M | -279.68M | -270.40M | |
| Cash from Financing | -- | -47.51M | -34.03M | -35.28M | |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | |
| Net Change in Cash | -- | 5.69M | 3.30M | 3.12M | |